KA

Kamada

KMDA
NASDAQHealth Care
$7.46
USD
+0.00(0.00%)
At close: Jun 16, 20:00 UTC

Open

$7.44

Prev. Close

$7.44

High

$7.46

Low

$7.43

Market Snapshot

Market Cap

$430.34M

P/E Ratio

21.1

EPS

0.25

Revenue

$160.95M

Employees

393

About

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 393 full-time employees. The company went IPO on 2005-08-01. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Recently from Cashu